首页> 外国专利> RWL-1 Pharmaceutical composition for preventing or treating gastrointestinal disorder comprising as an active ingredient a compound isolated from Bacillus amyloliquefaciens RWL-1 culture medium

RWL-1 Pharmaceutical composition for preventing or treating gastrointestinal disorder comprising as an active ingredient a compound isolated from Bacillus amyloliquefaciens RWL-1 culture medium

机译:RWL-1预防或治疗胃肠道疾病的药物组合物,其包含从解淀粉芽孢杆菌RWL-1培养基中分离的化合物作为活性成分。

摘要

The present invention relates to a composition for preventing, improving, and treating gastrointestinal diseases comprising a compound isolated from a culture of Bacillus amyloliquefaciens RWL-1 strain, isolated from Bacillus amyloliquefaciens species It is the first description of the enzyme inhibitory activity of a bioactive compound. Since the composition of the present invention has excellent urease inhibitory activity, it has the effect of inhibiting the urease activity of Helicobacter pylori and making Helicobacter pylori difficult to survive in the gastric mucosa. It is expected to be useful in the medical and food industry by using water as an important source of bioactive metabolites with high therapeutic value.
机译:本发明涉及用于预防,改善和治疗胃肠道疾病的组合物,该组合物包含从解淀粉芽孢杆菌RWL-1菌株的培养物中分离的化合物,该化合物是从解淀粉芽孢杆菌种中分离的。 。由于本发明的组合物具有优异的脲酶抑制活性,因此具有抑制幽门螺杆菌的脲酶活性并使幽门螺杆菌难以在胃粘膜中存活的作用。通过将水用作具有高治疗价值的生物活性代谢物的重要来源,有望将其用于医疗和食品行业。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号